Truist Securities Assumes Jazz Pharmaceuticals (JAZZ) at Buy
Buy
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Buy
What happened, with direct paths to the underlying reporting
JAZZ target $256; current price $232.04; Truist assumes Buy.
Target: $256
Posted price: $232.04
Analyst firm: Truist Financial
Analyst: Gregory Renza
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.